![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 7127L
GW Pharmaceuticals PLC
08 July 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ---------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying GW Pharmaceuticals plc issuer of existing shares to which voting rights are attached: ------------------------------------------------- ------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights ------------------------------------------------------------------------------- ------- Other (please specify): ------------------ ----------------------------------------------------------- ------- 3. Full name of person(s) subject The Capital Group Companies, Inc. to the notification obligation: ------------------------------------------ -------------------------------------------- 4. Full name of shareholder(s) Capital Research and Management Company (if different from 3.): ------------------------------------------ -------------------------------------------- 5. Date of the transaction and date 3 July 2014 on which the threshold is crossed or reached: ------------------------------------------ -------------------------------------------- 6. Date on which issuer notified: 7 July 2014 ------------------------------------------ -------------------------------------------- 7. Threshold(s) that is/are crossed Above 10% or reached: ------------------------------------------ -------------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares ------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE --------------- ------------------------------------ ----------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of rights Shares Voting shares Rights --------------- -------------- -------------------- --------- ----------------------- ----------------------------- Direct Direct Indirect Direct Indirect --------------- ---- ------ ------ ----- ----- --------- ---------- ----------- --------------- ------------ ADRs (US36197T1034) 1,947,957 23,375,484 23,855,484 10.111% --------------- -------------- -------------------- --------- ---------- ----------- --------------- ------------ B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion Period rights that may rights be acquired if the instrument is exercised/ converted. ----------------------- -------------- ----------------------------- ---------------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date Conversion rights instrument instrument period refers to ----------------- ------------ ------------- ---------------- ---------------------------- ------------------------ Nominal Delta ----------------- ------------ ------------- ---------------- ---------------------------- ------------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------------------- --------------------------------------------------------- 23,855,484 10.111% ------------------------------------------------------------- --------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: -------------------------------------------------------------------------------- Holdings by Capital Research and Management Company SMALLCAP World Fund, Inc Proxy Voting: -------------------------------------------------------------------------------- 10. Name of the proxy holder: --------------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------------- --------------------------- 13. Additional information: ---------------------------------------- -------------------------------------- 14. Contact name: Christopher Aquino ---------------------------------------- -------------------------------------- 15. Contact telephone number: 800-421-8511 ---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEANXPEFXLEEF
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions